These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 1715467)

  • 1. Scintigraphic assessment of cardiac adrenergic innervation in patients with essential hypertension.
    Fujiwara Y; Hamada M; Shigematsu Y; Sumimoto T; Hamamoto K; Hiwada K
    J Cardiovasc Pharmacol; 1991; 17 Suppl 2():S148-50. PubMed ID: 1715467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of [123I]MIBG to assess cardiac adrenergic innervation: experience in hypertensive cardiopathy and left ventricular aneurysms.
    Giordano A; Calcagni ML; Rufini V; Colivicchi F; Melina D; Melina G; Pristipino C; Nori S; Trani C; Santarelli P
    Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):44-8. PubMed ID: 9002748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Myocardial sympathetic activity and characteristics in hypertrophic cardiomyopathy: comparison with hypertensive hypertrophy].
    Narita M; Kurihara T
    J Cardiol; 1996 Mar; 27(3):133-41. PubMed ID: 8865685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Evaluation of hypertrophic cardiomyopathy with 123I-metaiodobenzylguanidine].
    Nakajima K; Bunko H; Taki J; Shimizu M; Nanbu I; Muramori A; Matsunari I; Hisada K
    Kaku Igaku; 1990 Jan; 27(1):33-8. PubMed ID: 2338765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical evaluation of 123I-BMIPP myocardial SPECT in patients with hypertensive heart disease and hypertrophic cardiomyopathy: comparison with the findings of 201Tl SPECT and Gd enhanced magnetic resonance imaging].
    Miyanaga H; Kawasaki S; Yoneyama S; Hyougo T; Kamitani T; Takahashi T; Kunishige H
    Kaku Igaku; 1997 Feb; 34(2):85-93. PubMed ID: 9095571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The mechanism of giant negative T wave in electrocardiogram in patients with apical hypertrophic cardiomyopathy: evaluation with thallium-201 and iodine-123 metaiodobenzylguanidine myocardial scintigraphy].
    Wang Y; Takigawa O; Handa S; Hatakeyama K; Suzuki Y
    Kaku Igaku; 1996 Sep; 33(9):999-1004. PubMed ID: 8921668
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative analysis of 123I-meta-iodobenzylguanidine (MIBG) uptake in hypertrophic cardiomyopathy.
    Nakajima K; Bunko H; Taki J; Shimizu M; Muramori A; Hisada K
    Am Heart J; 1990 Jun; 119(6):1329-37. PubMed ID: 2353619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Whole-body distribution of iodine 123 metaiodobenzylguanidine in hypertrophic cardiomyopathy: significance of its washout from the heart.
    Taki J; Nakajima K; Bunko H; Simizu M; Muramori A; Hisada K
    Eur J Nucl Med; 1990; 17(5):264-8. PubMed ID: 2128050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simultaneous assessment of regional adrenergic activity and perfusion with 123I-MIBG and 201Tl in congestive heart failure.
    Seto H; Shimizu M; Nozawa T; Yoshida N; Inagaki S; Kageyama M; Kakishita M
    Nucl Med Commun; 1996 Mar; 17(3):225-30. PubMed ID: 8692490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myocardial m-[123I]iodobenzylguanidine scintigraphy for the assessment of adrenergic cardiac innervation in patients with IDDM. Comparison with cardiovascular reflex tests and relationship to left ventricular function.
    Kreiner G; Wolzt M; Fasching P; Leitha T; Edlmayer A; Korn A; Waldhäusl W; Dudczak R
    Diabetes; 1995 May; 44(5):543-9. PubMed ID: 7729613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Myocardial imaging with 123I-metaiodobenzylguanidine (123I-MIBG) in essential hypertension: does the 123I-MIBG imaging have the ability to predict its prognosis?].
    Narita M; Kurihara T; Murano K; Usami M; Honda M
    Kaku Igaku; 1994 Aug; 31(8):879-89. PubMed ID: 7933677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Scintigraphic assessment of regional cardiac adrenergic innervation.
    Dae MW; O'Connell JW; Botvinick EH; Ahearn T; Yee E; Huberty JP; Mori H; Chin MC; Hattner RS; Herre JM
    Circulation; 1989 Mar; 79(3):634-44. PubMed ID: 2783894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Direct evidence of impaired cardiac sympathetic innervation in essential hypertensive patients with left ventricular hypertrophy.
    Kuwahara T; Hamada M; Hiwada K
    J Nucl Med; 1998 Sep; 39(9):1486-91. PubMed ID: 9744329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of cardiac sympathetic innervation with iodine-123-metaiodobenzylguanidine imaging in silent myocardial ischemia.
    Matsuo S; Takahashi M; Nakamura Y; Kinoshita M
    J Nucl Med; 1996 May; 37(5):712-7. PubMed ID: 8965132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Scintigraphic detection of regional disruption of the adrenergic nervous system in sarcoid heart disease.
    Misumi I; Kimura Y; Hokamura Y; Honda Y; Yasunaga T; Nakashima K; Takemura N; Asoshina M; Uranaka N; Takenaka S; Shima K
    Jpn Circ J; 1996 Oct; 60(10):774-8. PubMed ID: 8933240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Myocardial imaging with 123I-MIBG and 201Tl].
    Bunko H; Nakajima K; Hisada K
    Nihon Rinsho; 1991 Jan; 49(1):125-9. PubMed ID: 2002590
    [No Abstract]   [Full Text] [Related]  

  • 17. Abnormal cardiac adrenergic nerve function in patients with syndrome X detected by [123I]metaiodobenzylguanidine myocardial scintigraphy.
    Lanza GA; Giordano A; Pristipino C; Calcagni ML; Meduri G; Trani C; Franceschini R; Crea F; Troncone L; Maseri A
    Circulation; 1997 Aug; 96(3):821-6. PubMed ID: 9264488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The heterogeneity of myocardial sympathetic innervation in normal subjects: an assessment by iodine-123 metaiodobenzylguanidine scintigraphy].
    D'Alto M; Maurea S; Basso A; Varrella P; Polverino W; Bianchi U; Bonelli A; Salvatore M; Chiariello M
    Cardiologia; 1998 Nov; 43(11):1231-6. PubMed ID: 9922590
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiac 123I-MIBG reflects left ventricular functional reserve in patients with nonobstructive hypertrophic cardiomyopathy.
    Isobe S; Izawa H; Iwase M; Nanasato M; Nonokawa M; Ando A; Ohshima S; Nagata K; Kato K; Nishizawa T; Murohara T; Yokota M
    J Nucl Med; 2005 Jun; 46(6):909-16. PubMed ID: 15937299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The significance of 201Tl/123I MIBG (metaiodobenzylguanidine) mismatched myocardial regions for predicting ventricular tachycardia in patients with idiopathic dilated cardiomyopathy].
    Maeno M; Ishida Y; Shimonagata T; Hayashida K; Toyama T; Hirose Y; Nagata M; Miyatake K; Uehara T; Nishimura T
    Kaku Igaku; 1993 Oct; 30(10):1221-9. PubMed ID: 8264112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.